4 ms·
Seeing the headline I shrugged and thought to myself, "oh, I bet it's rapamycin again." That and a few other old cancer drugs routinely get studied for antiagi
by maxander 10y ago
Seeing the headline I shrugged and thought to myself, "oh, I bet it's rapamycin again." That and a few other old cancer drugs routinely get studied for antiaging effects- which is cool, but somewhat less than directly applicable because of the side-effects associated with what is essentially chemo.
But here the drug is apparently a peptide, so it's presumably somewhat more benign (at least relative, mind you, to chemo.) Also easily synthesizable! I wonder if an amino acid sequence can be patented?
- JPLeRouzic 10y agoI am not a biologist but the whole business of senolytics is to mess with the cell cycle. That is not something benign.
- maxander 10y agoNot really the cell cycle per se, but yes, the idea is to poison senescent cells. But it can be benign to the organism as a whole nonetheless.